China National Accord Medicines Corporation Ltd.

SZSE:000028 Stock Report

Market Cap: CN¥15.2b

China National Accord Medicines Balance Sheet Health

Financial Health criteria checks 5/6

China National Accord Medicines has a total shareholder equity of CN¥21.7B and total debt of CN¥4.3B, which brings its debt-to-equity ratio to 19.9%. Its total assets and total liabilities are CN¥52.0B and CN¥30.3B respectively. China National Accord Medicines's EBIT is CN¥1.9B making its interest coverage ratio -29. It has cash and short-term investments of CN¥5.4B.

Key information

19.9%

Debt to equity ratio

CN¥4.30b

Debt

Interest coverage ratio-29x
CashCN¥5.43b
EquityCN¥21.65b
Total liabilitiesCN¥30.33b
Total assetsCN¥51.98b

Recent financial health updates

Recent updates

Lacklustre Performance Is Driving China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E

Nov 18
Lacklustre Performance Is Driving China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E

China National Accord Medicines Corporation Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 30
China National Accord Medicines Corporation Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

China National Accord Medicines (SZSE:000028) Seems To Use Debt Quite Sensibly

Oct 10
China National Accord Medicines (SZSE:000028) Seems To Use Debt Quite Sensibly

China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E No Reason For Excitement

Aug 13
China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E No Reason For Excitement

Estimating The Intrinsic Value Of China National Accord Medicines Corporation Ltd. (SZSE:000028)

Jul 12
Estimating The Intrinsic Value Of China National Accord Medicines Corporation Ltd. (SZSE:000028)

Is China National Accord Medicines (SZSE:000028) A Risky Investment?

Jun 12
Is China National Accord Medicines (SZSE:000028) A Risky Investment?

Improved Earnings Required Before China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Find Their Feet

May 12
Improved Earnings Required Before China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Find Their Feet

Analysts Are Updating Their China National Accord Medicines Corporation Ltd. (SZSE:000028) Estimates After Its Full-Year Results

Apr 10
Analysts Are Updating Their China National Accord Medicines Corporation Ltd. (SZSE:000028) Estimates After Its Full-Year Results

China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Could Be 28% Below Their Intrinsic Value Estimate

Mar 15
China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Could Be 28% Below Their Intrinsic Value Estimate

China National Accord Medicines (SZSE:000028) Has A Rock Solid Balance Sheet

Feb 29
China National Accord Medicines (SZSE:000028) Has A Rock Solid Balance Sheet

Financial Position Analysis

Short Term Liabilities: 000028's short term assets (CN¥40.7B) exceed its short term liabilities (CN¥28.1B).

Long Term Liabilities: 000028's short term assets (CN¥40.7B) exceed its long term liabilities (CN¥2.2B).


Debt to Equity History and Analysis

Debt Level: 000028 has more cash than its total debt.

Reducing Debt: 000028's debt to equity ratio has increased from 16.2% to 19.9% over the past 5 years.

Debt Coverage: 000028's debt is well covered by operating cash flow (64%).

Interest Coverage: 000028 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies